REGULUS THERAPEUTICS INC (RGLS) Forecast, Price Target & Analyst Ratings

NASDAQ:RGLS • US75915K3095

8.16 USD
+0.02 (+0.25%)
At close: Jun 24, 2025
8.02 USD
-0.14 (-1.72%)
After Hours: 6/24/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REGULUS THERAPEUTICS INC (RGLS).

Forecast Snapshot

Consensus Price Target

Price Target
$8.67
+ 6.25% Upside

Next Earnings Forecast

Earnings Estimate
Release DateAug 6, 2025
PeriodQ2 / 2025
EPS Estimate-$0.22
Revenue Estimate

ChartMill Buy Consensus

Rating
73.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.67
Upside
+ 6.25%
From current price of $8.16 to mean target of $8.67, Based on 12 analyst forecasts
Low
$7.07
Median
$8.16
High
$11.55

Price Target Revisions

1 Month
-3.41%
3 Months
-27.97%

Price Target Summary

12 analysts have analysed RGLS and the average price target is 8.67 USD. This implies a price increase of 6.25% is expected in the next year compared to the current price of 8.16.
The average price target has been revised downward by 27.97% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RGLS Current Analyst RatingRGLS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

RGLS Historical Analyst RatingsRGLS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
73.33%
RGLS was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about RGLS.
In the previous month the buy percentage consensus was at a similar level.
RGLS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-05-01Wells FargoDowngrade Overweight -> Equal-Weight
2025-04-30Leerink PartnersDowngrade Outperform -> Market Perform
2025-04-30Jones TradingDowngrade Buy -> Hold
2025-04-30Canaccord GenuityDowngrade Buy -> Hold
2025-03-27Wells FargoUpgrade Equal-Weight -> Overweight
2025-03-17Canaccord GenuityMaintains Buy -> Buy
2025-03-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-14OppenheimerReiterate Outperform -> Outperform
2024-08-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-25Canaccord GenuityMaintains Buy -> Buy
2024-06-25HC Wainwright & Co.Maintains Buy -> Buy
2024-05-31Jones TradingInitiate Buy
2024-05-10HC Wainwright & Co.Reiterate Buy
2024-05-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-25HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-19Canaccord GenuityMaintains Buy -> Buy
2024-03-18Leerink PartnersInitiate Outperform
2024-03-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-13Wells FargoMaintains Equal-Weight -> Equal-Weight
2023-09-21Canaccord GenuityMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateAug 6, 2025
PeriodQ2 / 2025
EPS Estimate-$0.22
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-27.20%
Number of Analysts8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
1.85%
EPS (3 Months)
12.40%

Next Earnings Summary

RGLS is expected to report earnings on 8/6/2025. The consensus EPS estimate for the next earnings is -0.22 USD and the consensus revenue estimate is 0 USD.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
RGLS revenue by date.RGLS revenue by date.
72K6.832M
9,388.89%		10.006M
46.46%
-100.00%		90.168M342.28M
279.60%		700.62M
104.69%		1.393B
98.82%		258.06M
-81.47%
EBITDA
YoY % growth
RGLS ebitda by date.RGLS ebitda by date.
-44.501M
34.18%		-15.903M
64.26%		-13.688M
13.93%		N/A
-99.86%		N/A
-2.78%		-31.314M
-9.83%		-50.898M
-60.91%		-63.24M
-27.26%		-86.7M
-37.10%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
RGLS ebit by date.RGLS ebit by date.
-46.763M
33.32%		-16.834M
64.00%		-14.155M
15.91%		-28.069M
-96.51%		-29.407M
-1.52%		-31.569M
-10.16%		-51.837M
-60.85%		-56.692M
-13.29%		-72.72M
-28.27%		18.88M
125.96%		243.25M
1,188.40%		561.75M
130.94%		1.18B
110.06%		103.02M
-91.27%
Operating Margin
RGLS operating margin by date.RGLS operating margin by date.
-64,948.61%-246.40%-141.47%N/AN/AN/AN/AN/AN/A20.94%71.07%80.18%84.71%39.92%
EPS
YoY % growth
RGLS eps by date.RGLS eps by date.
-55.20
58.56%		-11.00
80.07%		-5.50
50.00%		-3.33
40.00%		-1.80
42.42%		-1.62
16.32%		-0.87
45.28%		-0.92
-5.52%		-1.08
-17.56%		-0.12
88.66%		1.76
1,537.50%		4.23
140.58%		8.48
100.24%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth		-0.22
-27.20%		-0.26
-21.43%		-0.27
-34.64%		-0.28
-83.60%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-14.251M
-16.24%		-16.948M
-11.43%		-18.063M
-31.41%		-14.215M
-34.89%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RGLS Yearly Revenue VS EstimatesRGLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
RGLS Yearly EPS VS EstimatesRGLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.97%
EPS Next 5 Year
47.01%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REGULUS THERAPEUTICS INC / RGLS Forecast FAQ

What do analysts expect the price target to be for REGULUS THERAPEUTICS INC (RGLS)?

12 analysts have analysed RGLS and the average price target is 8.67 USD. This implies a price increase of 6.25% is expected in the next year compared to the current price of 8.16.


What is the next earnings date for RGLS stock?

REGULUS THERAPEUTICS INC (RGLS) will report earnings on 2025-08-06, after the market close.


What are the consensus estimates for REGULUS THERAPEUTICS INC (RGLS) next earnings?

The consensus EPS estimate for the next earnings of REGULUS THERAPEUTICS INC (RGLS) is -0.22 USD and the consensus revenue estimate is 0 USD.


How many analysts have analysed REGULUS THERAPEUTICS INC (RGLS)?

The number of analysts covering REGULUS THERAPEUTICS INC (RGLS) is 12.